Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synvivia has developed a proprietary genetically encoded biocontainment system using engineered protein switches that act as ON-OFF controls for living cells and organisms. These switches respond to small molecule signals and can be used to control or contain genetically modified organisms across various environments—including blood and nonsterile soil—enabling safer deployment of synthetic biology solutions outside the laboratory. The technology has been validated in complex biological conditions and aims to address safety concerns limiting broader adoption of engineered organisms in fields such as gene therapy manufacturing, agriculture, energy production, food supply chains, and materials science.[1][2][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synvivia.